| Question 1: Which of these is the parent committee to SPG (i.e., is immediately above SPG in the AAPM organizational structure)? |
| Reference: | http://www.aapm.org/org/structure/default.asp?committee_code=PICR |
| Choice A: | Strategic Planning Committee. |
| Choice B: | Administrative Council. |
| Choice C: | Professional Council. |
| Choice D: | Clinical Practice Committee. |
| Question 2: Which of the following is one of the SPG committee charges? |
| Reference: | http://www.aapm.org/org/charges/spg.asp |
| Choice A: | Edit clinical information in all Task Group reports. |
| Choice B: | Evaluate scientific content of all Task Group reports. |
| Choice C: | Evaluate all draft Task Group reports prior to publication, to determine whether a Clinical Implementation Guide would be appropriate and of benefit to AAPM members. |
| Choice D: | To oversee AAPM activities which directly impact the practice environment. This includes interaction with corporate affiliates. |
| Question 3: Though the MPPG initiative started in 2011, in what year was SPG approved? |
| Reference: | http://www.aapm.org/org/structure/default.asp?committee_code=SPG |
| Choice A: | 2007. |
| Choice B: | 2010. |
| Choice C: | 2013. |
| Choice D: | 2016. |
| Question 4: MPPG refers to: |
| Reference: | AAPM Publications MPPG landing page: www.aapm.org/pubs/MPPG
|
| Choice A: | A Method for Procuring Protective Gear. |
| Choice B: | The federal agency for radiological protection. |
| Choice C: | Medical Physics Practice Guidelines, a series of guidelines developed by the AAPM to clearly define the minimum level of medical physics support for certain clinical services. |
| Choice D: | Varian’s latest accelerator technology with Maximum Performance Per Gantry angle. |
| Choice E: | The new Medicare reimbursement scheme. |
| Question 5: The intention of the MPPGs is to: |
| Reference: | Chan MF, Prisciandaro JI, Shepard SJ, and Halvorsen PH. Medical Physics Practice Guidelines – the AAPM’s minimum practice recommendations for medical physicists. J Appl Clin Med Phys 14(6):1-4, 2013. |
| Choice A: | Provide good practice recommendations for research. |
| Choice B: | Replace traditional AAPM Task Group reports. |
| Choice C: | Describe the minimum level of medical physics support the AAPM deems prudent in all clinical practice settings. |
| Choice D: | Define residency program curriculum requirements. |
| Choice E: | Create an official AAPM physics accreditation program. |
| Question 6: MPPGs are published: |
| Reference: | AAPM Publications MPPG landing page: www.aapm.org/pubs/MPPG |
| Choice A: | In the journal Medical Physics, available only to subscribers. |
| Choice B: | As AAPM Monographs available from the AAPM by request. |
| Choice C: | In the journal Medical Physics, designated as Open Access. |
| Choice D: | In the open-access Journal of Applied Clinical Medical Physics. |
| Choice E: | By the ACR. |
| Question 7: Personal Supervision means: |
| Reference: | AAPM Professional Policy 18: www.aapm.org/org/policies/policy.asp?type=PP |
| Choice A: | Supervising oneself |
| Choice B: | The responsible professional defines the SOP for the procedure but does not need to be in the facility during patient procedures. |
| Choice C: | The responsible professional defines the SOP for the procedure and monitors via CCTV or WebEx. |
| Choice D: | The responsible professional has determined the competency of each staff. |
| Choice E: | The responsible professional exercises General Supervision and is present in the room during the performance of the procedure. |
| Question 8: According to MPPG 5.a, planar or volumetric measurements for IMRT and VMAT commissioning should be evaluated with which gamma evaluation criterion? |
| Reference: | Smilowitz, J. B., Das, I. J., Feygelman, V., Fraass, B. A., Kry, S. F., Marshall, I. R., Mihailidis, D. N., Ouhib, Z., Ritter, T., Snyder, M. G. and Fairobent, L. (2015), AAPM Medical Physics Practice Guideline 5.a.: Commissioning and QA of Treatment Planning Dose Calculations — Megavoltage Photon and Electron Beams. Journal of Applied Clinical Medical Physics, 16: 14–34. doi:10.1120/jacmp.v16i5.5768 |
| Choice A: | 2%/2mm. |
| Choice B: | 3%/3mm. |
| Choice C: | 5%/3mm. |
| Choice D: | The guideline makes no recommendation for evaluation criteria. |
| Question 9: Which of the following describes why using a stricter gamma criteria is
valuable during commissioning?
|
| Reference: | Nelms, B. E., Chan, M. F., Jarry, G., Lemire, M., Lowden, J., Hampton, C. and Feygelman, V. (2013), Evaluating IMRT and VMAT dose accuracy: Practical examples of failure to detect systematic errors when applying a commonly used metric and action levels. Med. Phys., 40: n/a, 111722. doi:10.1118/1.4826166 |
| Choice A: | Stricter criteria can identify easily correctable modeling errors. |
| Choice B: | Stricter criteria can highlight weaknesses in a dose calculation algorithm. |
| Choice C: | Stricter criteria are more sensitive to changes in beam model parameters. |
| Choice D: | All of the above. |
| Choice E: | None of the above. |
| Question 10: After you have completed MPPG 5.a for a treatment machine, you may reuse your measured data to perform all of the following EXCEPT: |
| Reference: | Jacqmin, D. J., Bredfeldt, J. S., Frigo, S. P. and Smilowitz, J. B. (2017), Implementation of the validation testing in MPPG 5.a “Commissioning and QA of treatment planning dose calculations–megavoltage photon and electron beams”. J Appl Clin Med Phys, 18: 115–127. doi:10.1002/acm2.12015 |
| Choice A: | Validation of a new treatment planning system for the same machine. |
| Choice B: | Validation of a dose calculation algorithm after a treatment planning system software upgrade. |
| Choice C: | Validation of a dose calculation model for a different treatment machine. |
| Choice D: | Validation of a secondary check dose calculation algorithm for the same machine. |
